CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Practical considerations when administering surfactants to preterm infants with respiratory distress syndrome
Heui Seung Jo
Clin Exp Pediatr. 2019;62(12):440-441.   Published online August 16, 2019
DOI: https://doi.org/10.3345/kjp.2019.00374

Excel Download

Practical considerations when administering surfactants to preterm infants with respiratory distress syndrome
Korean Journal of Pediatrics. 2019;62(12):440-441   Crossref logo
Link1 Link2 Link3

Risk of bilirubin acid precipitation in preterm infants with respiratory distress syndrome: considerations of blood/brain bilirubin transfer equilibrium
Early Human Development. 1982;6(4):341-355   Crossref logo
Link1 Link2

Parental representations of preterm infants with a respiratory distress syndrome
Pediatric Pulmonology. 1997;23(S16):256-256   Crossref logo
Link1 Link2

Persistent pulmonary hypertension in preterm infants with respiratory distress syndrome
Pediatric Pulmonology. 2001;26(S23):103-106   Crossref logo
Link1 Link2

Alternative therapies for respiratory distress syndrome in preterm infants
Research and Reports in Neonatology. 2011;67   Crossref logo
Link1

Persistent pulmonary hypertension in preterm infants with respiratory distress syndrome
Pediatric Pulmonology. 2001;32(S23):103-106   Crossref logo
Link1 Link2

Oxygenation index as a respiratory parameter of respiratory distress syndrome in preterm infants
Korean Journal of Pediatrics. 2008;51(2):145   Crossref logo
Link1

Discovery Labs announces FDA approval of Surfaxin (lucinactant) for prevention of respiratory distress syndrome
Focus on Surfactants. 2012;2012(5):5   Crossref logo
Link1 Link2

Acorda Therapeutics awarded grant to study ARCUS technology in respiratory distress syndrome
Focus on Surfactants. 2015;2015(9):5   Crossref logo
Link1 Link2

A new clinical respiratory distress score for surfactant therapy in preterm infants with respiratory distress
European Journal of Pediatrics. 2019;   Crossref logo
Link1 Link2 Link3